iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
A CDX2 result is one piece of a pathology assessment, not a diagnosis of colon cancer or a test that identifies a tumor’s starting point by itself. Positive staining can support intestinal differentiation; negative staining does not rule out colorectal cancer. To understand what the result means for a particular case, read it alongside the final diagnosis, the tumor’s appearance and location, other stains, and the clinical information available to the pathologist.
What CDX2 immunohistochemistry measures
CDX2 is a transcription factor associated with intestinal epithelial differentiation. Immunohistochemistry, often shortened to IHC, uses an antibody-based stain to show whether a selected protein is detectable in cells in a tissue sample. In this context, the pathologist assesses whether tumor cells show the expected CDX2 staining under that laboratory’s assay and interpretation criteria.
The result is evidence about a feature of the tumor cells. It is not, on its own, a complete cancer diagnosis, a determination of where the cancer began, or a treatment recommendation. Its significance depends on how the cells look under the microscope, where the specimen came from, and how CDX2 fits with the other findings.
PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchIn other words, the stain answers a narrower question than many readers expect: does this sample show CDX2 in the tumor cells according to the method and criteria used? It does not directly answer whether the tumor began in the colon, whether it has spread from somewhere else, or what treatment should be given. Those questions require the pathologist and care team to interpret the stain in the context of the entire case.
#1 Best Overall
- Powerful Turbo Fan:CAGIWIRU Electric Air Duster have reached speed up to 130000RPM,Can efficient remove dust and debris.With LED light and Three Adjustable Speed to meet with different cleaning tasks.
- With Attached USB C Fasting Charging cable.Charing 3 hours,Enjoy up to 240 minutes of use on the lowest setting, For third speed can use for 25mins.with four charging options to meet with your needs.
- Wide Application:Upgraded attached 5 different nozzles,making it suitable for a variety of scenes, such as car,pet, pc, keyboards, and other electronic devices. It also serves for office and home clean duster.
- Handy Design & Portable:Cordless air duster electric nozzle is Light weight and small size, design and comfortable to hold and space saving, convenient to carry around. You can put it in your room or inside the car without taking up space.
- Warranty & Support: Our Electric air duster comes with 5 years warranty and 24/7 customer service. During this period, if you have any questions,pls kindly feel free to contact us.
The wording can also reflect differences in laboratory methods and scoring rules. A report’s result should therefore be understood as the pathologist’s interpretation of staining in that specimen, not as a universal measurement that can be compared without context to every other report.
What “CDX2 positive” means
“Positive” generally means the tumor cells show staining for CDX2 according to the laboratory’s criteria. In a tumor that already looks like an adenocarcinoma, a positive result can support intestinal differentiation and may help the pathologist consider a colorectal or another intestinal primary.
That support is not proof of origin. CDX2 expression is not exclusive to colorectal tumors. It has been described in other tumor types, including some intestinal tumors and some neuroendocrine neoplasms. A positive result therefore has to be interpreted with the pattern of staining and the rest of the case, rather than treated as a binary “colon cancer” test.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →“Intestinal differentiation” describes a characteristic of the tumor cells; it is not interchangeable with “the tumor started in the intestine.” A tumor may show a feature associated with intestinal cells without that feature identifying its primary site by itself. Conversely, a suspected intestinal primary is assessed through the combined pattern of pathology, specimen information, and clinical findings.
Does CDX2 positive mean colon cancer?
No—not by itself. The result may contribute to a conclusion about possible intestinal origin, but it cannot independently establish that a tumor started in the colon. The final pathology diagnosis reflects the combined evidence, which may include tumor morphology, the specimen site, the patient’s history, other immunostains, imaging, and separate molecular findings when indicated.
For example, the same positive result may be weighed differently depending on whether the cells look like an adenocarcinoma, what tissue was sampled, and what other stains show. The result can support a possibility, but it does not settle the question independently. If a report says CDX2 is positive, the next useful step is to find the final diagnosis and any comment that explains how the stain contributed to it.
What “CDX2 negative” means
“Negative” means the tumor cells did not show the expected staining under the criteria used for that report. It weakens one possible line of support for intestinal differentiation, but it does not independently exclude colorectal cancer. Some colorectal cancers can lose CDX2 expression, and staining may be heterogeneous rather than uniform.
Recommended Free Tools
A 2008 study in Modern Pathology reported CDX2 negativity in 21.6% of MSI-high colorectal cancers in that study’s cohort. This is a cohort-specific observation—not a universal rate, a measure of the test’s sensitivity in every setting, or an estimate of an individual patient’s chance of having colorectal cancer.
Rank #2
- Screen Cleaner is Your Screen’s New Bestfriend! - EVEO is proud to present a screen cleaner that’s perfectly suited for your TV. Meet your new screen cleaner, computer screen cleaner, laptop cleaner, iPad cleaner, Macbook,tv cleaner or any other electronic device. Our screen cleaner spray and wipe along with the included plush microfiber cloth, easily removes dust, fingerprints & other smudges on the screen’s surface. Clean effectively for a streak-free screen
- Gentle on your Screens - Our screen cleaner spray and wipes is compatible to be used even for the most sensitive LCD, LED, CRT, and OLED screens in proper use. Be at ease knowing that this product is compatible with all the major brands: LG, SONY, Samsung, Sharp, iPad, iPhone, Android screens, Kindle, PC monitors - we’ve got you covered! Can be used as LCD screen cleaner, tv cleaner, smart tv screen cleaner, and more
- Premium Super Soft Plush Microfiber Cloth - Included in this efficient screen cleaning kit. This screen cleaner spray and wipe has our signature plush microfiber cloth specially designed to comply with screens and monitors and leave them streak-free. Has been shown to effectively absorbs stubborn stains, zero streaks, and no fiber shedding. Always use this together with our screen cleaner for the best results
- Easy-to-Use Screen Cleaner Kit + microfiber cleaning cloth - The EVEO Screen Cleaning Kit will easily be your new favorite tool when it comes to taking care of the things you love most, quick and easy solution for a streak-free screen. Simply screw on the sprayer gun on the screen cleaner bottle. Spray the cleaning liquid onto the microfiber cloth, then wipe the screen until desired cleanliness & shine is achieved.
- Quality Screen Care Kit Worth Purchasing - Enjoy a convenient Screen Cleaner anytime, anywhere you need it. Your satisfaction is our top priority. We stand behind the quality of our products and that’s why, you shouldn’t be worrying at all. We manufacture the Best Screen Cleaner. and can be used for laptop cleaning kit, laptop screen cleaner, tv screen cleaner for smart tv. MacBook screen cleaner, monitor cleaner or screen cleaner spray for electronic devices with microfiber cleaning cloth
The practical point is that a negative stain must be reconciled with the morphology, specimen location, other marker results, and clinical picture. The pathologist may still consider colorectal origin when the rest of the evidence supports it.
A negative result is therefore best read as “the expected CDX2 staining was not identified under this report’s criteria,” rather than as “colorectal cancer has been ruled out.” Whether the finding changes the leading interpretation depends on what question the stain was selected to address and how the other evidence compares. If the tumor’s appearance or other findings point in another direction, the overall diagnosis may reflect that. If they continue to support an intestinal or colorectal possibility, absence of CDX2 alone does not erase those findings.
The 21.6% figure is useful as a reminder that CDX2 loss can occur in a particular colorectal cancer subgroup, but it should not be applied as a general probability. It describes the MSI-high colorectal cancers in one 2008 cohort, not all colorectal cancers, all laboratories, or a specific person’s case. It also does not tell a reader the MSI status of their own tumor. MSI status must be determined by the separate tests used for that purpose.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →How to interpret positive, negative, focal, or patchy wording
| Report wording | What it describes | What it does not establish on its own |
|---|---|---|
| Positive | Tumor-cell staining is present according to the laboratory’s criteria. The pathologist considers its location, extent, and intensity. | It does not prove the primary site or mean the tumor must be colorectal. |
| Negative | Tumor-cell staining is absent according to the report’s criteria. | It does not rule out colorectal cancer. |
| Focal or patchy | Staining is present in only some cells or areas of the sample. | It does not have one universal interpretation independent of controls, assay, specimen, and laboratory criteria. |
Staining is not always an all-or-nothing observation. Extent, intensity, nuclear localization, internal controls, and the laboratory’s scoring approach can affect how the result is described and interpreted. For example, a 2023 colorectal carcinoma study described an approach in which any nuclear staining, even if patchy, counted as no loss when internal controls were positive. That is a study-specific interpretation approach; do not assume every laboratory uses identical criteria or wording.
If the report says “focal,” “patchy,” or “loss,” the most useful clarification is how the pathologist interpreted that pattern in this specimen—not an assumption that the word has the same scoring meaning in every laboratory.
“Focal” or “patchy” describes distribution: some tumor cells or areas stain while others do not. It does not automatically mean that the result is positive or negative under every laboratory’s formal scoring system. The report may describe the observed pattern, then provide an interpretation based on the assay, controls, and the criteria the laboratory applies. A phrase such as “loss” may likewise have a specific meaning in the context of a study or a laboratory protocol.
Nuclear localization matters because CDX2 is assessed as a nuclear marker. A reader should not assume that any color or stain seen somewhere on a slide necessarily represents the expected tumor-cell staining. Internal controls are also part of interpretation: they help the pathologist assess whether the staining run behaved as expected in the tissue. The 2023 study’s approach—counting any nuclear staining, even patchy, as no loss when internal controls were positive—is an example of a defined approach, not a universal instruction for reading all reports.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
When a report includes a pattern descriptor, read it alongside the pathologist’s comment rather than trying to convert it into a diagnosis. Useful details to ask about include whether staining was nuclear, whether it was present in tumor cells, how extensive it was, and whether controls were satisfactory. The pathologist can explain whether the pattern supports, weakens, or does not materially change the interpretation in that particular case.
Rank #3
- 【Large size】：Measuring 800 x 300 mm/ 31. 5×12 inches, which is wider and taller than others. Large mouse pad can perfectly fit your keyboard and mouse of any size, and there is also ample space for peripherals such as phones, tablets, etc.
- 【LED backlight mouse pad】：Blade Hawks RGB mouse pad provides 7 static modes and 7 dynamic modes will give you the options you are looking for. Power-off memory function remembers the last lighting mode you selected. The super glow fiber Chroma will give you a colorful gaming setup that you want.
- 【Anti-slip rubber base】：Made from Natural rubber, this gaming mousepad will firmly grip your desktop, allowing you to enjoy the ultimate precision in the games you are most passionate about. It also comes with a texture that enhances this ability even further.
- 【Smooth and waterproof surface】: Micro-textured cloth surface, for extremely precise mouse control and a smooth movement. When liquid splashes on the gaming mouse pad, it forms water droplets and slides down. Will not delay your work or gameplay.
- 【Plug and play】: This mouse and keyboard pad is powered by USB, plug and play, no driver required. One button control light modes. Press one time to change the lighting mode, press twice to change the brightness, press and hold about 3 seconds turn ON/OFF.
How CDX2 fits with other pathology evidence
When a pathologist is considering possible tumor origins, no single stain should be read as a stand-alone origin test. CDX2 is interpreted with the tumor’s morphology and the site and history of the specimen. Other immunostains may be selected to address the specific differential diagnosis; CK7 and CK20 are among the markers that may be discussed alongside CDX2.
The pattern across findings matters. A CDX2 result is one part of an evidence set that can include:
- Morphology: what the tumor cells and tissue architecture look like under the microscope.
- Specimen site and history: where the sample was obtained and what is known about the patient’s prior diagnoses and clinical circumstances.
- Immunostains: CDX2 and other markers selected by the pathologist, including CK7 and CK20 when relevant.
- Imaging and clinical findings: information the care team uses alongside pathology to assess the case.
- Separate molecular findings: results of any additional tests that are relevant to the diagnostic question.
The combination may support or weaken a proposed origin, but the weight of each finding depends on the particular case. The same CDX2 wording can have different significance in different specimens because the surrounding evidence differs.
This is why a pathology report may list multiple stains rather than relying on CDX2 alone. Each marker is selected to address a diagnostic question, and the results are interpreted as a pattern. CK7 and CK20, for example, may be considered alongside CDX2, but a reader should not treat any one of these stains as a standalone answer. The report’s conclusion reflects the way the stains fit with morphology and the available clinical information.
When comparing possible sites, the pathologist is weighing several kinds of evidence rather than checking off a single positive or negative result. The specimen site tells where the sample was taken, not necessarily where a tumor began. Morphology describes what the tumor looks like. Immunostains provide additional evidence about cellular features. Imaging and history can help establish what possibilities are clinically relevant, while separate molecular findings may address other questions. These categories can reinforce or complicate one another.
As a result, a stain that supports intestinal differentiation does not necessarily override a mismatch between the tumor’s morphology and the proposed site. Nor does a negative stain necessarily outweigh other evidence that supports that site. The relative importance of a finding is a case-level interpretation, not something a reader can determine from the marker name alone.
If you are trying to understand whether a tumor is primary or metastatic, ask how the report describes the specimen and what conclusion it reaches about origin. CDX2 may be one component of that assessment, but the stain itself does not establish whether the sample represents a primary tumor or a tumor that has spread from elsewhere.
CDX2 is not MMR or MSI testing
CDX2 IHC is separate from mismatch-repair (MMR) protein IHC and microsatellite-instability (MSI) testing. A CDX2 result does not report whether a tumor is MMR-deficient or MSI-high, does not establish Lynch syndrome risk, and does not determine eligibility for immune checkpoint therapy.
Rank #4
- 【Softer and More Comfortable】Vaydeer wrist rest has unique diamond pattern, which is the combination of softness and aesthetics. The materials of wrist rest are improved into higher quality memory foam and covered with silky smooth lycra. The computer wrist rest makes you as comfortable and cushiony as like rest your wrists on clouds.
- 【Ergonomic Wrist Saver】The wrist rests for keyboard and mouse comes with a 17.32×3.15×0.83 inch keyboard wrist pad and a 5.94×3.15×0.83 inch mouse wrist support. Based on ergonomic design, the unique concave shape is the perfect fit for your wrist joints. The wrist rest pad fits most computer keyboards and laptops, improve hand and wrist posture, release your wrist and arm stress.
- 【Non-Slip Rubber Bottom】Featuring an anti-skid silicone base on the bottom, this wrist keyboard support stays firmly in place on your desk, preventing the padding from sliding around, ensuring stable and consistent wrist support during extended computer sessions.
- 【Better Experience & Pain Relief】Our keyboard arm rest is beneficial to alleviate the soreness caused by direct contact and friction between your arm and a hard desk surface, reducing the risk of wrist fatigue or carpal tunnel. The soft texture of memory foam can evenly distribute the pressure around your wrists and provide good support with just enough give.
- 【Helpful in Multiple Scenarios】Whether you're working, studying, writing, typing, gaming, this keyboard and mouse rest combo is an essential accessory to add comfort and support to your hands and wrists. It’s also a great gift for men, women, family, friend, coworker, gamer, teacher, etc.
The College of American Pathologists’ MMR/MSI guideline addresses those separate tests and their role in selecting patients for immune checkpoint therapy. If the report or care team is discussing MMR, MSI, hereditary risk, or immunotherapy, look for the corresponding test results rather than inferring them from CDX2.
These terms can appear in discussions of the same cancer, but they answer different questions. CDX2 is a marker associated with intestinal epithelial differentiation. MMR and MSI testing assess other tumor features and have separate clinical implications. The fact that CDX2 is a protein stain does not make it an MMR test, and a CDX2-positive or CDX2-negative line cannot substitute for the MMR or MSI result.
Likewise, the 21.6% CDX2-negative finding reported among MSI-high colorectal cancers in the 2008 Modern Pathology cohort does not allow someone to infer that an individual tumor is MSI-high. It shows that CDX2 loss was observed in that specific group; it is not a method for determining a patient’s MSI category. If MMR or MSI status matters to the care discussion, ask whether those tests were performed and where their results appear in the report.
Free tools Windows power users keep installed
One-click scans. No signup required.
What CDX2 cannot tell you by itself
A CDX2 result alone does not establish the primary site, provide a complete cancer diagnosis, give the cancer stage or prognosis, or specify a treatment plan. Those conclusions depend on the full pathology diagnosis and other relevant clinical findings. Mayo Clinic Laboratories notes: “Interpretation of this test should be performed in the context of the patient’s clinical history and other diagnostic tests by a qualified pathologist.” Its test-catalog information describes technical stain performance and explicitly does not include pathologist interpretation.
Similarly, a colorectal biomarker guideline from the ASCP, CAP, AMP, and ASCO addresses biomarkers used in colorectal cancer management and emphasizes clear reporting of results and relevant limitations. It is not a CDX2-specific treatment guideline. Do not use a CDX2 result alone to infer a management recommendation.
The College of American Pathologists’ 2017 colorectal biomarker guideline provides broader context for why biomarker results need careful reporting: it includes 21 statements—eight recommendations, ten expert consensus opinions, and three no-recommendation statements—and its evidence review considered more than 4,000 articles. Those figures describe the guideline’s scope; they do not make it a CDX2-specific guideline or turn CDX2 into a treatment-selection test.
For a reader, the distinction is practical. A laboratory test page may explain how a stain is technically performed, but that is not the same as the pathologist’s interpretation of the individual specimen. The final diagnosis and comments in the pathology report are the place to look for that interpretation. If the clinical team is making decisions about staging, prognosis, or therapy, those decisions require information beyond CDX2 and should be discussed with the treating clinician.
How to read the result in your report
- Find the final diagnosis first. Identify the report’s diagnosis and the specimen site. The diagnosis is the pathologist’s overall conclusion; the CDX2 line is one finding contributing to it.
- Locate the CDX2 result and its comment. Note whether the report says positive, negative, focal, patchy, or uses another description. Check whether it specifies extent, intensity, nuclear staining, or interpretation.
- Review the other stains in the same panel. Note which other markers were tested and whether the pathologist explains how the pattern supports or argues against a possible origin. Do not interpret CK7, CK20, or another marker in isolation either.
- Look for separate MMR/MSI or molecular results. These are different tests and may appear elsewhere in the report or in a separate report. A CDX2 result is not a substitute.
- Ask the treating clinician or pathologist to connect the findings. They can explain how the staining pattern relates to the specimen, the final diagnosis, and any additional clinical information.
It can help to read the report in layers. Start with the diagnosis, then identify the specimen described, then read the comment or interpretive note that explains how the tests were used. The list of individual stains is supporting information; it may not state the final conclusion by itself. If results are spread across an initial report and addenda or separate molecular reports, ask the care team whether all relevant findings are available before drawing conclusions.
Best Value
- 【No Drill Mounted】Cable management tray can be assembled in as little as 3 minutes or less-simply. Side clips easily clampe the edge of desk, pass through the holes on the sides, and secure excess cables with baskets. Desk cable management supports inward or outward installation to meet your needs in different scenarios, and provides you with great convenience when collecting and organizing wires.
- 【Rubber Pad Protects Desk】Wire organizer under desk built-in soft rubber pads on the clamp protect your desk from scratches, so you will not damage your furniture or office.
- 【Sturdy and Beautiful】Cord management under desk is made of high-quality carbon steel and holds about 15 lbs. The wire basket has 2 holes on each side of the tray to enable your cables to pass freely. Cable baskets are suitable for desk thickness use from 0.4" to 2.4".
- 【Space Saving & Keep Organized】Desk cable management tray holds all your power cords, outlet strips, USB hubs and computer transformers hidden from your feet, and the data cables will not enter the vacuum cleaner to keep your desk clean and tidy. Desk wire organizer is also suitable for use in the kitchen and outdoors.
- 【Reduce Safety Risks】Cable tray under desk keeps all plugs away from your kids, no more worry about tripping. Using 2 holes wire tray saves extra space, helps you easily cabling and wire protection. The mesh design is not easy to accumulate dust, but avoids safety accidents caused by messy wires.
When reviewing a result, avoid translating a single word into a broader conclusion. “Positive” does not mean “colon cancer confirmed,” and “negative” does not mean “colorectal cancer excluded.” “Focal” and “patchy” describe distribution but do not carry an identical scoring implication across all laboratories. The report’s own interpretation and the treating team’s explanation are more useful than a general rule detached from the case.
Useful questions for your care team
- What diagnosis does the full pathology report give, and what specimen site does it refer to?
- Is CDX2 staining present in the tumor cells, and was it diffuse or focal?
- How did the pathologist interpret the staining pattern and any internal controls?
- Which other immunostains were performed, and how do their results fit together?
- Is CDX2 being used to assess a possible primary site in this case?
- Are MMR/MSI or other molecular tests reported separately, and what question are those tests addressing?
You can also ask what uncertainty remains after the stains are considered and whether any additional tests are being used to answer a separate question. If a report describes CDX2 as negative despite other findings that suggest intestinal differentiation, ask how the pathologist reconciled the results. If the report says positive, ask whether that result supports a particular interpretation or is simply one piece of the overall panel.
These questions focus on what the result means in the actual report rather than trying to assign a diagnosis from one stain. Individual interpretation belongs with a qualified pathologist and the treating clinician, who can consider the full record.
Frequently Asked Questions
What does CDX2 positive mean in a pathology report?
It means tumor cells show CDX2 staining under the laboratory’s criteria. CDX2 is associated with intestinal epithelial differentiation, so a positive result may support an intestinal origin in context. It does not prove that the tumor began in the colon or establish a diagnosis by itself.
Does CDX2 positive mean colon cancer?
No. CDX2 can support consideration of a colorectal or other intestinal primary, but it is not exclusive to colorectal tumors and has been described in other tumor types, including some neuroendocrine neoplasms. The final interpretation depends on morphology, specimen site, other stains, history, imaging, and any relevant molecular findings.
Does a negative CDX2 result rule out colorectal cancer?
No. Some colorectal cancers can lose CDX2 expression. A 2008 Modern Pathology study reported CDX2 negativity in 21.6% of MSI-high colorectal cancers in its cohort; that figure is not a universal rate or a patient-specific probability. The rest of the pathology and clinical evidence still matters.
What does focal or patchy CDX2 staining mean?
It describes staining in only some cells or areas. Its significance depends on the assay, internal controls, specimen, and the laboratory’s criteria. A 2023 colorectal carcinoma study described an approach in which any nuclear staining, even patchy, counted as no loss when internal controls were positive; that approach should not be assumed to apply to every laboratory.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Clear out junk files and repair common Windows errors3Fix the driver behind crashes, sound loss and screen glitchesIs CDX2 the same as MMR or MSI testing?
No. CDX2 IHC is separate from mismatch-repair protein IHC and microsatellite-instability testing. A CDX2 result does not report MMR or MSI status, establish Lynch syndrome risk, or determine immune checkpoint therapy eligibility.
Can CDX2 tell me the cancer stage, prognosis, or treatment?
No. CDX2 alone does not establish the primary site, complete diagnosis, stage, prognosis, or treatment plan. Those questions require the full pathology interpretation and relevant clinical findings; discuss them with the treating clinician.
Who can explain how CDX2 was interpreted in my case?
A qualified pathologist or treating clinician can connect the stain with the final diagnosis, specimen, other immunostains, clinical history, and any separate testing. Mayo Clinic Laboratories advises that test interpretation be performed in the context of clinical history and other diagnostic tests by a qualified pathologist.
The Bottom Line
CDX2 is a marker associated with intestinal differentiation, not a stand-alone test for where a tumor began. Positive staining can support an intestinal or colorectal origin in context; negative staining does not rule out colorectal cancer. Read the result with the full pathology diagnosis, morphology, specimen site, other stains, and relevant clinical findings. CDX2 is also separate from MMR/MSI testing, so ask your care team to explain how each result fits the question being evaluated.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
